1,25-Dihydroxyvitamin D3 Promotes a Sustained LPS-Induced NF-κB-Dependent Expression of CD55 in Human Monocytic THP-1 Cells

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Izban, Michael G ^a   Nowicki, Bogdan J ^a   Nowicki, Stella ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CD11B ANTIGEN; CD14 ANTIGEN; DECAY ACCELERATING FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR IMMUNITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MONOCYTE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANTIGENS, CD11B; ANTIGENS, CD14; ANTIGENS, CD55; CELL LINE; COMPLEMENT SYSTEM PROTEINS; GENE EXPRESSION REGULATION; HUMANS; KINETICS; LIPOPOLYSACCHARIDES; MONOCYTES; NF-KAPPA B; RNA, MESSENGER; SIGNAL TRANSDUCTION; VITAMIN D;

BACTERIA (MICROORGANISMS);

EID: 84869018684     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049318     Document Type: Article

References (63)

1. Holers VM, (2008) The spectrum of complement alternative pathway-mediated diseases. Immunol Rev 223: 300-316.
2. Wuding Z, (2012) The new face of anaphylatoxins in immune regulation. Immunobiology 217: 225-234.
3. Girardi G, Bulla R, Salmon JE, Tedesco F, (2006) The complement system in the pathophysiology of pregnancy. Mol Immunol 43: 68-77.
4. Lublin DM, (2005) Review: Cromer and DAF: role in health and disease. Immunohematology 21: 39-47.
5. Lukacik P, Roversi P, White J, Esser D, Smith GP, et al. (2004) Complement regulation at the molecular level: The structure of decay-accelerating factor. Proc Nat Acad Sci USA 101: 1279-1284.
6. Köhl JR, (2001) Anaphylatoxins and infectious and non-infectious inflammatory diseases. Mol Immunol 38: 175-187.
7. Li K, Fazekasova H, Wang N, Peng Q, Sacks SH, et al. (2012) Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology 217: 65-73.
8. Lawrence DW, Bruyninckx WJ, Louis NA, Lublin DM, Stahl GL, et al. (2003) Antiadhesive role of apical decay-accelerating factor (CD55) in human neutrophil transmigration across mucosal epithelia. J Exp Med 198: 999-1010.
9. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686.
10. Saha P, Modarai B, Humphries J, Mattock K, Waltham M, et al. (2009) The monocyte/macrophage as a therapeutic target in atherosclerosis. Curr Opin Pharmacol 9: 109-118.
11. Sendide K, Reiner NE, Lee JS, Bourgoin S, Talal A, et al. (2005) Cross-talk between CD14 and complement receptor 3 promotes phagocytosis of mycobacteria: regulation by phosphatidylinositol 3-kinase and cytohesin-1. J Immunol 174: 4210-4219.
12. Dobrovolskaia MA, Vogel SN, (2002) Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 4: 903-914.
13. Hawley KL, Olson CM, Iglesias-Pedraz JM, Navasa N, Cervantes JL, et al. (2012) CD14 cooperates with complement receptor 3 to mediate MyD88-independent phagocytosis of Borrelia burgdorferi. Proc Nat Acad Sci USA 109: 1228-1232.
14. Ehlers MRW, (2000) CR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes Infect 2: 289-294.
15. Le Cabec V, Cols C, Maridonneau-Parini I, (2000) Nonopsonic phagocytosis of zymosan and mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation. Infect Immun 68: 4736-4745.
16. Gangloff SC, Zahringer U, Blondin C, Guenounou M, Silver J, et al. (2005) Influence of CD14 on ligand interactions between lipopolysaccharide and its receptor complex. J Immunol 175: 3940-3945.
17. Nowicki S, Izban MG, Pawelczyk E, Agboto VK, Pratap S, et al. (2009) Preterm labor: CD55 in maternal blood leukocytes. Am J Reprod Immunol 61: 360-367.
18. Pacheco LD, Hankins GD, Costantine MM, Anderson GD, Pawelczyk E, et al. (2011) The role of human decay-accelerating factor in the pathogenesis of preterm labor. Am J Perinatol 28: 565-570.
19. Ruland J, (2011) Return to homeostasis: downregulation of NF-κB responses. Nat Immunol 12: 709-714.
20. Bonizzi G, Karin M, (2004) The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288.
21. Sharif O, Bolshakov V, Raines S, Newham P, Perkins N, (2007) Transcriptional profiling of the LPS induced NF-κB response in macrophages. BMC Immunology 8: 1.
22. Schreiber J, Jenner RG, Murray HL, Gerber GK, Gifford DK, et al. (2006) Coordinated binding of NF-κB family members in the response of human cells to lipopolysaccharide. Proc Natl Acad Sci USA 103: 5899-5904.
23. Christmas SE, de la Mata Espinosa CT, Halliday D, Buxton CA, Cummerson JA, et al. (2006) Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes. Immunology 119: 522-528.
24. Li K, Fazekasova H, Wang N, Sagoo P, Peng Q, et al. (2011) Expression of complement components, receptors and regulators by human dendritic cells. Mol Immunol 48: 1121-1127.
25. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C, (2010) Vitamin D: a pleiotropic hormone. Kidney Int 78: 140-145.
26. Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, et al. (2009) Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6: 231-243.
27. Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A, (2006) Vitamin D decreases NFκB activity by increasing IκBα levels. Nephrol Dial Transplant 21: 889-897.
28. Griffin MD, Dong X, Kumar R, (2007) Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: A paradigm for ligand-augmented negative transcriptional regulation. Arch Biochem Biophys 460: 218-226.
29. Kovacs CS, Kronenberg HM, (1997) Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18: 832-872.
30. Evans KN, Bulmer JN, Kilby MD, Hewison M, (2004) Vitamin D and placental-decidual function. J Soc Gynecol Invest 11: 263-271.
31. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, et al. (2007) Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 92: 3517-3522.
32. Bodnar LM, Catov JM, Zmuda JM, Cooper ME, Parrott MS, et al. (2010) Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. J Nutr 140: 999-1006.
33. Shibata M, Suzuki A, Sekiya T, Sekiguchi S, Asano S, et al. (2011) High prevalence of hypovitaminosis D in pregnant Japanese women with threatened premature delivery. J Bone Miner Metab 29: 615-620.
34. Hughes PJ, Marcinkowska E, Gocek E, Studzinski GP, Brown G, (2010) Vitamin D3-driven signals for myeloid cell differentiation- Implications for differentiation therapy. Leuk Res 34: 553-565.
35. Campbell FC, Xu H, El Tanani M, Crowe P, Bingham V, (2010) The Yin and Yang of vitamin D receptor (VDR) signaling in neoplastic progression: Operational networks and tissue-specific growth control. Biochem Pharmacol 79: 1-9.
36. Rachez C, Freedman LP, (2000) Mechanisms of gene regulation by vitamin D3 receptor: a network of coactivator interactions. Gene 246: 9-21.
37. Moeenrezakhanlou A, Nandan D, Shephard L, Reiner NE, (2007) 1α,25-Dihydroxycholecalciferol activates binding of CREB to a CRE site in the CD14 promoter and drives promoter activity in a phosphatidylinositol-3 kinase-dependent manner. J Leukoc Biol 81: 1311-1321.
38. Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, et al. (2005) Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol 19: 2685-2695.
39. Moeenrezakhanlou A, Shephard L, Lam L, Reiner NE, (2008) Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase. J Leukoc Biol 84: 519-528.
40. Holla VR, Wang D, Brown JR, Mann JR, Katkuri S, et al. (2004) Prostaglandin E2 regulates the complement inhibitor CD55/decay accelerating factor in colorectal cancer J Biol Chem. 280: 476-483.
41. Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN, (2011) 1,25(OH)2Vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 152: 2976-2986.
42. Hmama Z, Nandan D, Sly L, Knutson KL, Herrera-Velit P, et al. (1999) 1α,25-Dihydroxyvitamin D3-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. J Exp Med 190: 1583-1594.
43. Szeles L, Keresztes G, Torocsik D, Balajthy Z, Krenacs L, et al. (2009) 1,25-Dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol 182: 2074-2083.
44. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
45. Zhang DE, Hetherington CJ, Gonzalez DA, Chen HM, Tenen DG, (1994) Regulation of CD14 expression during monocytic differentiation induced with 1α,25-dihydroxyvitamin D3. J Immunol 153: 3276-3284.
46. Schwende H, Fitzke E, Ambs P, Dieter P, (1996) Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J Leukoc Biol 59: 555-561.
47. Nahid MA, Pauley KM, Satoh M, Chan EKL, (2009) MiR-146A is critical for endotoxin-induced tolerance. Implication on innate immunity. J Biol Chem 284: 34590-34599.
48. Weichhart T, Säemann MD, (2009) The multiple facets of mTOR in immunity. Trends in Immunology 30: 218-226.
49. Lee DH, Goldberg AL, (1998) Proteasome inhibitors: valuable new tools for cell biologists. Trends in Cell Biology 8: 397-403.
50. Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM, (2001) The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IκB kinase. Chem Biol 8: 759-766.
51. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, et al. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-771.
52. Klos A, Tenner AJ, Johswich KO, Ager RR, Reis ES, et al. (2009) The role of the anaphylatoxins in health and disease. Molecular Immunology 46: 2753-2766.
53. Hayden MS, Ghosh S, (2008) Shared principles in NF-κB signaling. Cell 132: 344-362.
54. Friedman AD, (2002) Transcriptional regulation of granulocyte and monocyte development. Oncogene 21: 3377-3390.
55. Klug M, Heinz S, Gebhard C, Schwarzfischer L, Krause SW, et al. (2010) Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels. Genome Biol 11: R63.
56. Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, et al. (2001) CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 166: 574-581.
57. Mellett M, Atzei P, Jackson R, O'Neill LA, Moynagh PN, (2011) Mal mediates TLR-induced activation of CREB and expression of IL-10. J Immunol 186: 4925-4935.
58. Triantafilou M, Lepper PM, Briault CD, Ahmed MA, Dmochowski JM, et al. (2008) Chemokine receptor 4 (CXCR4) is part of the lipopolysaccharide "sensing apparatus". Eur J Immunol 38: 192-203.
59. Mason JC, Steinberg R, Lidington EA, Kinderlerer AR, Ohba M, et al. (2004) Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-α/ε (PKCα/ε)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A. J Biol Chem. 279: 41611-41618.
60. El Gazzar M, Church A, Liu T, McCall CE, (2011) MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-α during TLR4-induced gene reprogramming. J Leukoc Biol 90: 509-519.
61. Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, et al. (2009) The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31: 220-231.
62. Chen M, Daha MR, Kallenberg CGM, (2010) The complement system in systemic autoimmune disease. J Autoimmun 34: J276-J286.
63. Davis LM, Chang SC, Mancini J, Nathanson MS, Witter FR, et al. (2010) Vitamin D insufficiency is prevalent among pregnant African American adolescents. J Pediatr Adolesc Gynecol 23: 45-52.